Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Advancing Breast cancer Individualised Generative AI for Longitudinal Outcomes

Objective

ABIGAIL4D pioneers a new approach to personalised oncology by developing and validating a 4D Generative AI system prototype that can learn disease evolution over time and support safer, more informed treatment decisions in early breast cancer. Today, decision support tools rely on static or single-modality data and cannot estimate how an individual patient would respond to alternative therapies. This limits clinical ability to compare options and optimise outcomes.
ABIGAIL4D combines multimodal longitudinal data, including imaging, pathology, genomics, and clinical variables, into a temporal model that reconstructs and forecasts tumour response, survival and toxicity. The system introduces counterfactual analysis to estimate patient-specific benefit and risk for different treatment strategies, such as escalation and de-escalation of chemotherapy or radiotherapy. Specialised AI agents (Radiology, Pathology, Oncology and Patient) collaborate through a stateful orchestrator to generate explainable recommendations with quantified uncertainty. Clinicians remain in control at all times, supported by transparent rationales linked to clinical concepts and guidelines.
The methodology follows a staged design: requirements co-creation with clinicians; development of the GenAI backbone and multi-agent framework; trust-by-design mechanisms for traceability, reproducibility and explainability; and validation in controlled, multi-centre lab settings. Regulatory documentation aligned with EU Medical Device Regulation and the AI Act will support future certification.
ABIGAIL4D AI agents and system, aim at enabling in the future personalised treatment decisions and more efficient care pathways. Expected benefits will include better therapy selection, fewer unnecessary scans and reduced burden for patients and healthcare systems. ABIGAIL4D provides a foundation for future expansion to other solid tumours, contributing to Europe’s leadership in responsible AI driven precision medicine

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2025-PATHFINDERCHALLENGES-01

See all projects funded under this call

Coordinator

FUNDACIO EURECAT
Net EU contribution
€ 898 875,00
Address
AVENIDA UNIVERSITAT AUTONOMA 23
08290 Cerdanyola Del Valles (Barcelona)
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
No data

Participants (9)